The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kieffer Tara Lynn since 2023.
This trader's CIK number is 1834835.
At the time of last reporting, Kieffer Tara Lynn was the Chief Product Strategy Officer of Enanta Pharmaceuticals Inc. (stock ticker symbol ENTA).
Also see all insider trading activities at Enanta Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ENTA | 0 | $0 | 9,549 | $107,989 | 0 | $0 |
| 2023 | ENTA | 0 | $0 | 2,125 | $20,463 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-06 | ENTA | Sale | 2,283 | 8.06 | 18,400 |
| 2024-06-17 | ENTA | Sale | 7,266 | 12.33 | 89,589 |
| 2023-12-05 | ENTA | Sale | 2,125 | 9.63 | 20,463 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kieffer Tara Lynn (Chief Product Strategy Officer of Enanta Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.